Articles

The BRAINEATERS series consider an artist’s experiences of diagnosis, routine surveillance, and ongoing reorientation to her future.

Fostering transgender patients’ sense of agency should be a clinical and ethical priority.

Invisibility of racial inequity and gender inclusion in clinical research means key features of disease etiology and symptom presentation are unaccounted for.

Clinicians can practice disability humility by developing social understandings of disability.

Patients writing daily journal briefs about work-related activities and pain can help clinicians help them.

Adhering too strictly to biomedical thinking about diagnosis can prevent clinicians from empathically engaging with patients and helping them navigate their illness experiences.

Patients’ perceptions of how much input they have in making health decisions influence therapeutic alliance and outcomes.

Public and self-stigma negatively influence patients’ quality of life, employment, and housing opportunities.

Hyperfocus on measurability can result in evidentiary overreliance and undervaluation of patients’ experience narratives.

Pharmaceuticals make symptoms and biological drug targets more visible but can render individual and community suffering less visible.